Table 2. Relationship between Syk expression and clinicopathologic characteristics through IHC in 57 patients with OSCC.
| Characteristics | n (%) | Syk expression | P | |
|---|---|---|---|---|
| Low | High | |||
| Gender | ||||
| Male | 32(56) | 20 | 12 | |
| Female | 25(44) | 20 | 5 | 0.1518 |
| Age (y) | ||||
| <60 | 30(53) | 26 | 4 | |
| ≥60 | 27(47) | 14 | 13 | 0.0041 |
| Pathologic stage | ||||
| I,II | 40(70) | 28 | 12 | |
| III,IV | 17(30) | 12 | 5 | 0.9646 |
| T stage | ||||
| T1-2 | 39(68) | 29 | 10 | |
| T3-4 | 18(32) | 11 | 7 | 0.3095 |
| Lymph node metastasis | ||||
| Negative | 51(88) | 37 | 13 | |
| Positive | 7(12) | 3 | 4 | 0.0916 |
| Recurrence | ||||
| No | 53(93) | 39 | 14 | |
| Yes | 4(7) | 1 | 3 | 0.0405 |
| Postoperative therapy | ||||
| No | 29(51) | 20 | 9 | |
| Chemo- or radiotherapy | 28(49) | 20 | 8 | 0.8390 |